Monday, January 10, 2022

Serum Institute Seeks Emergency Use Approval Of Covovax In South Africa

Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant...

from NDTV News - Latest https://ift.tt/3zHDv9E
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers

India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian ...